01/30/2026 | Press release | Distributed by Public on 01/30/2026 11:30
The Commonwealth is investing $100 million to support the manufacturing site's project in the Lehigh Valley - the largest life sciences investment in PA history.
Pennsylvania, which competed aggressively against other states to win this Lilly project, is the only Northeast state with a growing economy and is a top destination for life sciences companies.
Since taking office, the Shapiro Administration has attracted over $39 billion in private-sector investment, creating more than 21,500 good-paying jobs statewide.
Allentown, PA -  Today, Governor Josh Shapiro and Pennsylvania Department of Community & Economic Development (DCED) Secretary Rick Siger announced the Commonwealth has secured a $3.5 billion private-sector investment from global pharmaceutical firm Eli Lilly and Company to build a new, state-of-the-art pharmaceutical manufacturing facility in Lehigh County. Lilly's investment is the largest by a life sciences company in Commonwealth history.
Supported by $100 million in Commonwealth investment, this expansion project will create at least 850 new jobs over the next five years and continue growing Pennsylvania's robust pharmaceutical and life sciences industries.
Lilly is purchasing a site in Fogelsville. This will be the first Lilly manufacturing facility in Pennsylvania and represents a long-term commitment to the Commonwealth from one of the world's leading drugmakers.
"When we announced our Economic Development Strategy here in the Lehigh Valley two years ago, we set out to win historic, life-changing deals like the one we're announcing with Lilly today," said Governor Josh Shapiro. "Before I took office, Pennsylvania wasn't even in the conversation for major investments like this, but thanks to our work to cut red tape, invest in site development, and expand our workforce, our Commonwealth is now competing - and winning - on a national scale. Lilly's commitment to the Lehigh Valley and to Pennsylvania will bring billions of dollars of investment and hundreds of good-paying jobs, solidifying our position as a leader in the growing life sciences industry."
Lilly received a funding proposal from DCED for up to $50 million in tax credits through the PA Edge Tax Credit Program, a $25 million grant through the PA SITES (Pennsylvania Strategic Investments to Enhance Sites) Program, and a $25 million Pennsylvania First grant.
The state has also committed to providing a Redevelopment Assistance Capital Program (RACP) award of up to $5 million to a local community college and/or technical school to help create a workforce development training program that would serve as a talent pipeline for the company in the Lehigh Valley.
"Lilly's investment is an important win for the Lehigh Valley and the entire Commonwealth, creating at least 850 new jobs and further solidifying our position as a leader in economic development and life science innovation," said Secretary Siger. "This announcement also further proves that our Economic Development Strategy is working to attract historic, new investments to Pennsylvania. We will keep competing for major projects like this one that will continue to strengthen our life sciences industry, create good-paying jobs, and fuel economic growth across the Commonwealth."
Lilly manufactures and distributes products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. Their products are sold in approximately 95 countries. Established in 1876 by Colonel Eli Lilly, the company was an early mass producer of insulin and the polio vaccine. Lilly develops and manufactures various prescription medications across therapeutic areas, including cardiometabolic health, oncology, immunology and neuroscience.
"Our mission starts with patients and delivering the medicines they need. To meet increasing demand, we're expanding our U.S. manufacturing network, with Lehigh Valley adding capacity for next-generation weight-loss medicines. We're creating high-quality jobs and collaborating across the region-with suppliers, educators, and workforce-development partners-to make critical medicines in the U.S.," said David A. Ricks, Lilly chair and CEO. "That's our commitment-to patients, to our new Pennsylvania home and to our country."
Lilly is also receiving assistance through Pennsylvania's Office of Transformation and Opportunity (OTO) on the project via the PA Permit Fast Track Program.
In November 2024, the Governor signed Executive Order 2024-04, creating the PA Permit Fast Track Program to streamline the Commonwealth's permitting process for key economic development and infrastructure projects, increase transparency, and accelerate timelines to ensure state government delivers results quickly and efficiently. Through OTO, the program helps develop, manage, and coordinate permitting for complex and impactful economic development and infrastructure projects across government agencies and private partners in order to get project sponsors answers in a timely manner.
Lilly's multi-billion-dollar expansion project represents a huge win for growing the life sciences industry in the Lehigh Valley and builds upon the excellence in this sector that has been developing in the region over the past several years.
"The Lehigh Valley is honored to welcome Lilly to the region," said Don Cunningham, President & CEO, Lehigh Valley Economic Development Corporation. "It took numerous key partners working behind the scenes in a multi-year process to attract Lilly and this multi-billion-dollar investment, but none more critical than Governor Shapiro and his excellent team. We're grateful for his leadership and partnership and the confidence and investment of Lilly."
Today's announcement is another example of how the Shapiro Administration is focused on supporting Pennsylvania's biotech ecosystem. Life sciences companies like Eurofins Lancaster Laboratories, Apozeal Pharmaceuticals, B. Braun, and GSK have announced expansions in Pennsylvania, bringing new jobs and R&D investments into the Commonwealth.
This project was coordinated by Governor Shapiro's BusinessPA team, an experienced group of economic development professionals dedicated to helping businesses succeed in Pennsylvania through tailored guidance, strategic partnerships, and financial resources. Whether based in the Commonwealth, another state, or across the globe, the team moves at the speed of business to set up companies for long-term growth and success here in Pennsylvania.
Pennsylvania's Business Climate and Growing Economy is Getting National Recognition
Pennsylvania's Business Climate and Growing Economy is Getting National Recognition
Learn more about the Shapiro Administration's efforts to support Pennsylvania's workers and businesses and spur the economy, and discover how the Administration is creating economic opportunity to build a stronger, more competitive economy for all Pennsylvanians.
For more information about the Department of Community and Economic Development, visit DCED website, and be sure to stay up-to-date with all of our agency news on Facebook, X, and LinkedIn.
MEDIA CONTACT: Governor's Press Office: [email protected]